X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Benign Prostatic Hyperplasia Companies

This report lists the top Benign Prostatic Hyperplasia companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Benign Prostatic Hyperplasia industry.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Chronic Disorder Drugs Research Oncology Drugs Research Benign Prostatic Hyperplasia Industry Companies

Benign Prostatic Hyperplasia Top Companies

  1. Allergan PLC

  2. Eli Lilly and Company

  3. Merck & Co., Inc.

  4. Boehringer Ingelheim

  5. Astellas Pharma Inc.

*Disclaimer: Top companies sorted in no particular order

Benign Prostatic Hyperplasia Market Major Players

Benign Prostatic Hyperplasia Market Concentration

Benign Prostatic Hyperplasia Market Concentration

Benign Prostatic Hyperplasia Company List

                            • Allergan PLC

                            • Astellas Pharma Inc.

                            • Boehringer Ingelheim

                            • Eli Lilly and Company

                            • GlaxoSmithKline PLC

                            • Nymox Pharmaceutical Corporation

                            • Pfizer Inc

                            • Sanofi

                            • Sophiris Bio Corp

                            • Teva Pharmaceutical Industries Limited


                        Specific to Benign Prostatic Hyperplasia Market
                        Need More Details On Market Players And Competitors?
                        Download Sample

                        Benign Prostatic Hyperplasia Market Report Snapshots

                        Benign Prostatic Hyperplasia Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)